People should check bottles of some own-brand children’s blackcurrant cough syrup to see if they need a replacement.
A problem with one of the ingredients in these medicines has been identified which could cause them to allow mould to grow. There is a low risk that the mould could make the child unwell or cause a reaction, although to date we are not aware of any cases where this has happened. As a precaution it has been decided to recall affected batches.
Only a small number of batches from 8 different products are being recalled. No other cough syrups are affected.
Dr Sam Atkinson, the Medicines and Healthcare products Regulatory Agency’s (MHRA) Director of the Inspection, Enforcement and Standards Division said:
Check if you have any of the listed cough syrups and if you do, please don’t use them. Take them back to where you bought them from.
The mould is not always visible, so return any of the affected cough syrup bottles, even if it looks okay to use. “If your child has recently taken one of these cough syrups, and, in the unlikely event that they have become unwell or had a reaction, please speak to your GP, pharmacist or other healthcare professional.
Our highest priority is making sure the medicines you and your family take are safe. This is why, even though there is a low risk of a reaction, we have asked the company to carry out this recall and why we want people to check their medicine cabinets.
As with any medicine, we strongly encourage anyone to report any suspected side effects to us via our Yellow Card Scheme.
Some valsartan containing products including certain batches supplied by Teva UK Limited and all unexpired batches supplied by Mylan are being recalled. Class 2 Medicines Recall: Teva UK Limited and... Read more →
UK pharmacies are assisting with the precautionary recall of Valsartan medication. The Medicines and Healthcare products Regulatory Agency (MHRA) are undertaking a pharmacy level recall of all affected batches of... Read more →
Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity Share Authorities in the EU are taking action after an impurity, N-nitrosodiethylamine... Read more →
At Fortissa we understand that importing and exporting premium healthcare products combined with optimum service levels is a key aspect of quality patient care. However we also understand that there is an environmental impact as a result; the energy used to procure, store, transport and distribute pharmaceuticals impacts on our environment in the form of CO2 emissions.
Whether pharmaceuticals are unavailable due to local market shortages, prescription, branded and unlicensed medicines are urgently required for clinical use, or you simply require reliable, regular deliveries of high quality medical supplies – Fortissa is your partner of choice for UK and international pharmaceutical wholesale.